R+D Pharma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Facultad de Farmacia, Universidade de Santiago de Compostela-Campus Vida, 15782, Santiago de Compostela, Spain.
R+D Pharma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Facultad de Farmacia, Universidade de Santiago de Compostela-Campus Vida, 15782, Santiago de Compostela, Spain; Departament of Chemical Engineering and Pharmaceutical Technology, Facultad de Ciencias de la Salud, Universidad de La Laguna (ULL), Campus de Anchieta, 38200, La Laguna, Spain.
Mater Sci Eng C Mater Biol Appl. 2020 Jan;106:110252. doi: 10.1016/j.msec.2019.110252. Epub 2019 Oct 13.
Local treatment of Inflammatory Bowel Disease (IBD) has been pointed out to be a novel therapeutic approach with several advantages when compared to conventional therapies. However, the development of systems able to fulfil the requirements of this administration route is not an easy task. The present work suggests the utilization of Artificial Intelligence Tools (AIT) as an instrument to understand polymer-polymer interactions towards obtaining thermosensitive hydrogels suitable for protein rectal administration in IBD. Enemas composed by Pluronic® F127 and F68 and Methocel® K4M were developed and characterised. Two experimental designs were carried out in order to determine the effect of each polymer on their texturometric and rheological behaviour. Using the results of the first experimental design we can justify the inclusion of each raw material PF127, PF68 and MK4M in the formulation and conclude that a compromise solution is necessary to obtain thermosensitive hydrogels of the required properties. The results of the second experimental design allowed concluding that PF127 ruled mainly syringeability and bioadhesion work. On the other hand, PF68 modulated principally gelation temperature, viscosity and protein release from hydrogel matrix. Finally, MK4M influenced bioadhesiveness and mostly determined viscosity. AIT also allowed delimiting the design space to produce easy administrable and highly bioadhesive enemas that undergo fast sol-gel transitions at body temperature.
局部治疗炎症性肠病(IBD)被指出是一种新的治疗方法,与传统疗法相比具有许多优势。然而,开发能够满足这种给药途径要求的系统并不是一件容易的事。本工作提出利用人工智能工具(AIT)作为一种手段,了解聚合物-聚合物相互作用,以获得适合 IBD 直肠给予蛋白质的温敏水凝胶。开发并表征了由 Pluronic® F127 和 F68 以及 Methocel® K4M 组成的灌肠剂。进行了两项实验设计,以确定每种聚合物对其质构和流变行为的影响。使用第一个实验设计的结果,我们可以证明每个原材料 PF127、PF68 和 MK4M 包含在配方中的合理性,并得出结论,需要找到一个折衷的解决方案才能获得具有所需性质的温敏水凝胶。第二个实验设计的结果表明,PF127 主要控制注射器可操作性和生物黏附功。另一方面,PF68 主要调节凝胶化温度、粘度和蛋白质从水凝胶基质中的释放。最后,MK4M 影响生物黏附性,主要决定粘度。AIT 还允许限定设计空间,以生产易于管理且具有高度生物黏附性的灌肠剂,这些灌肠剂在体温下迅速发生溶胶-凝胶转变。